Musk Keeps Tesla Open in Midst of Lockdown, Downplays Risk

Musk Keeps Tesla Open in Midst of Lockdown, Downplays Risk

(Bloomberg) -- Tesla Inc.’s factory and other California operations will remain open in the midst of a San Francisco Bay Area lockdown, with Elon Musk telling employees he will keep going in to work despite the spread of the coronavirus.“I’d like to be super clear that if you feel the slightest bit ill or even uncomfortable, please do not feel obligated to come to work,” the chief executive officer wrote to staff in an email seen by Bloomberg News. “I will personally be at work, but that’s just me.”Musk’s email didn’t specifically address whether Tesla will keep open its lone U.S. auto plant in Fremont, California. But his head of North American human resources sent a follow-up email saying that vehicle manufacturing and energy infrastructure are deemed crucial sectors, and that the factory will remain in operation despite Bay Area orders for people to stay home to limit the spread of...

Co-Diagnostics Sees 'Aggressive Expansion' In Coronavirus Test Distribution After FDA Policy Revision

Co-Diagnostics Inc (NASDAQ: CODX) shares were rallying Tuesday following an update from the company regarding its COVID-19 test. The molecular diagnostic company said a revised FDA policy on COVID-19 diagnostic testing that was announced Monday will allow the company to "aggressively expand" its presence in the U.S.FDA Eases Testing Rules An update to the FDA policy, originally issued Feb. 29, aims to create more rapid testing capacity in the U.S.The new measures, among other things, call for states to take responsibility for tests used by labs in the respective states.As opposed to the earlier rule allowing only high-complexity testing consistent with requirements under the Clinical Laboratory Improvement Amendments to carry out testing, the FDA now said it does not object to commercial manufacturers distributing and labs using new commercially developed tests prior to the agency granting emergency use authorization, or EUA, under certain circumstances. New Rules Widen Co-Diagnostics' Reach Due to...

Should You Buy WestRock Company (WRK)?

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]...

A Coronavirus Treatment Worth Watching

(Bloomberg Opinion) -- As the coronavirus crisis has unfolded, we’ve seen a a flood of announcements from drug companies touting potential treatments for the still incurable disease. Many have come from biotechnology companies that have never successfully developed a drug, let alone purpose-built one for an outbreak. Regeneron Pharmaceuticals Inc.'s announcement Tuesday that its development efforts are ahead of schedule — so much so that it  may be able to start human trials in early summer — is an exception that should provoke measured optimism.There's still a long road ahead and a lot of uncertainty. Even in a best-case scenario, a drug won't be tested for months and broad availability is even farther away. But if Covid-19 sticks around, there's at least a chance a Regeneron drug will be a tool used to fight it. In addition to developing blockbuster medicines, Regeneron has a demonstrated ability to respond to outbreaks.The company’s efforts are centered on using mice engineered with human-like immune systems...